BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Astrocytoma AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Prognosis
249 results:

  • 1. CD133 significance in glioblastoma development: in silico and in vitro study.
    Abdoli Shadbad M; Nejadi Orang F; Baradaran B
    Eur J Med Res; 2024 Mar; 29(1):154. PubMed ID: 38448914
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring the therapeutic mechanisms and prognostic targets of Biochanin A in glioblastoma via integrated computational analysis and in vitro experiments.
    Ge W; Yuan G; Wang D; Dong L
    Sci Rep; 2024 Feb; 14(1):3783. PubMed ID: 38360888
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating akt1 signaling.
    Wang B; Zhang X; Li ZS; Wei C; Yu RZ; Du XZ; He YJ; Ren Y; Zhen YW; Han L
    Cancer Lett; 2024 Mar; 585():216665. PubMed ID: 38290657
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma.
    Shaikh MAJ; Altamimi ASA; Afzal M; Gupta G; Singla N; Gilhotra R; Almalki WH; Kazmi I; Alzarea SI; Prasher P; Singh SK; Dua K
    Pathol Res Pract; 2024 Feb; 254():155121. PubMed ID: 38262269
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibitory Effects of Urolithins, Bioactive Gut Metabolites from Natural Polyphenols, against Glioblastoma Progression.
    Shen CK; Huang BR; Charoensaensuk V; Yang LY; Tsai CF; Liu YS; Lai SW; Lu DY; Yeh WL; Lin C
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068712
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. STEAP3 is a prognostic biomarker that promotes glioma progression by regulating immune microenvironment and PI3K-akt pathway.
    Song Z; Zhao Z; Zhu S; Jin Q; Shi Y; Zhang S; Wang Z; Wang Y; Zhao Z
    Cancer Biomark; 2023; 38(4):505-522. PubMed ID: 37980651
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/akt Signaling Pathways.
    Li H; Liu J; Qin X; Sun J; Liu Y; Jin F
    Cell Mol Neurobiol; 2023 Nov; 43(8):3929-3942. PubMed ID: 37747595
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Glioblastoma cellular MAP4K1 facilitates tumor growth and disrupts T effector cell infiltration.
    Sun JM; Fan HY; Zhu Y; Pan TT; Wu YP; Zhang DY; Hou XY
    Life Sci Alliance; 2023 Dec; 6(12):. PubMed ID: 37734869
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/akt pathway.
    Liang W; Liu M; Su Y; Wen Y; Wang L; Shan J; Zhao J; Xie K; Wang J
    IUBMB Life; 2024 Mar; 76(3):140-160. PubMed ID: 37728571
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC.
    Zheng SX; Chen J; Zhuang BB; Zhang Q; Shi SS; Zhang GL
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16055-16067. PubMed ID: 37695389
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Toward Precision Oncology in Glioblastoma with a Personalized Cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing.
    Erdogan O; Özkaya ŞÇ; Erzik C; Bilguvar K; Arga KY; Bayraklı F
    OMICS; 2023 Sep; 27(9):426-433. PubMed ID: 37669106
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway.
    Li C; Chen B; Zhang J; Yang J; Guo M; Ren Y; Zhou Z; Fung KM; Li M; Zhang L; Liu Z
    Cancer Lett; 2023 Nov; 577():216368. PubMed ID: 37652287
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/akt/mTOR/Snail pathway.
    Zheng L; Yang S; Xu R; Yang Y; Quan J; Lin Z; Quan C
    Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594082
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P
    Bergkamp ND; van Senten JR; Brink HJ; Bebelman MP; van den Bor J; Çobanoğlu TS; Dinkla K; Köster J; Klau G; Siderius M; Smit MJ
    Sci Signal; 2023 Aug; 16(798):eade6737. PubMed ID: 37582160
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PTPN11 variant may be a prognostic indicator of IDH-wildtype glioblastoma in a comprehensive genomic profiling cohort.
    Otani R; Ikegami M; Yamada R; Yajima H; Kawamura S; Shimizu S; Tanaka S; Takayanagi S; Takami H; Yamaguchi T
    J Neurooncol; 2023 Aug; 164(1):221-229. PubMed ID: 37552362
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MiR-4524b-5p-targeting ALDH1A3 attenuates the proliferation and radioresistance of glioblastoma via PI3K/akt/mTOR signaling.
    Yu H; Li X; Li Y; Wang T; Wang M; Mao P
    CNS Neurosci Ther; 2024 Feb; 30(2):e14396. PubMed ID: 37551838
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A prognostic biomarker NRG1 promotes U-87 MG glioblastoma cell malignancy by inhibiting autophagy via ERBB2/akt/mTOR pathway.
    Lin JZ; Lin N; Zhao WJ
    J Cell Biochem; 2023 Sep; 124(9):1273-1288. PubMed ID: 37450666
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection.
    Dal Bo M; Polano M; Ius T; Di Cintio F; Mondello A; Manini I; Pegolo E; Cesselli D; Di Loreto C; Skrap M; Toffoli G
    J Transl Med; 2023 Jul; 21(1):450. PubMed ID: 37420248
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Acrolein produced by glioma cells under hypoxia inhibits neutrophil akt activity and suppresses anti-tumoral activities.
    Tsai HC; Tong ZJ; Hwang TL; Wei KC; Chen PY; Huang CY; Chen KT; Lin YJ; Cheng HW; Wang HT
    Free Radic Biol Med; 2023 Oct; 207():17-28. PubMed ID: 37414347
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Chrysomycin A Regulates Proliferation and Apoptosis of Neuroglioma Cells via the akt/GSK-3β Signaling Pathway In Vivo and In Vitro.
    Liu DN; Liu M; Zhang SS; Shang YF; Zhang WF; Song FH; Zhang HW; Du GH; Wang YH
    Mar Drugs; 2023 May; 21(6):. PubMed ID: 37367654
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.